MONTREAL--(BUSINESS WIRE)--Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce the creation of a business partnership with the Montreal offices of Gowling WLG. “As we are progressing with the set-up of our small-scale production line in our Boucherville facilities and look ahead to our first marketing initiatives in the near future, it’s time to align our diverse intellectual property portfolio with our strategic objectives,” Charest explains.
Recognized IP expertise
With its long years of experience in patent law, Gowling WLG has a proven roadmap for international protection and enforcement of intellectual property rights in fields including biotechnology, clean technologies, and energy and pharmaceutical industry technologies, and has worked with clients ranging from innovative startups to universities, research institutes and multinational corporations.
“We immediately understood the full significance of Aplantex’s innovations and their potential benefits for the health and well-being of people all over the world. These innovations deserve to be well-protected, and we’re pleased to contribute to that protection through our proven expertise and extensive network of professionals,” says George Elvira, M. Sc., Ph.D., partner and registered patent agent in Canada and the United States for Gowling WLG.
Game-changing innovations
“It’s clear that our innovations are disrupting the field of plant-based active ingredient production and calling many of our competitors’ business models into question,” Patrick Charest explains. “So we need to be able to protect our innovations and defend our rights for the long term in order to maximize the value of our business. We’re fortunate to be able to rely on the valuable services and advice provided by Gowling WLG’s international network of experts.”
ABOUT APLANTEX
Aplantex scientists have developed a unique production process for plant-based active ingredients with high added value, a coveted resource for major players in a variety of industries. The core of this green biotechnology process is the continuous production of plant biomass from photosynthetic phytoreplicators in a controlled environment. This abundant biomass is then dried, and the subsequent extraction, fractionation and purification stages isolate the specific molecules that are essential to numerous products sought by the pharmaceutical, cosmetic and food industries.
ABOUT GOWLING WLG
Building on its initial strength in intellectual property law, Gowling WLG has diversified to offer a full range of services in business law, litigation and intellectual property for all of Canada’s key industries, including energy, mining, financial services, governmental affairs, infrastructure, manufacturing, life sciences and technology. Gowling WLG is one of Canada’s most active firms for mergers and acquisitions, and is renowned for its deep expertise in defending clients before Canada’s courts, tribunals, regulatory authorities and governments.
Contacts
Marc-André Ménard
450-531-2275
mamenard@aplantex.ca